These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22201953)

  • 21. [Association of Vitamin D Receptor Polymorphisms with Response to Antiviral Therapy in Patients with Chronic Hepatitis C].
    Wang C; Wu Q; Wei XT; Li ZZ; Lei XZ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Mar; 47(2):227-31. PubMed ID: 27263300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-acting antiviral therapy.
    Sriphoosanaphan S; Thanapirom K; Suksawatamnuay S; Thaimai P; Sittisomwong S; Sonsiri K; Srisoonthorn N; Teeratorn N; Tanpowpong N; Chaopathomkul B; Treeprasertsuk S; Poovorawan Y; Komolmit P
    BMC Gastroenterol; 2020 Oct; 20(1):346. PubMed ID: 33069226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D for your patients with chronic hepatitis C?
    Rahman AH; Branch AD
    J Hepatol; 2013 Jan; 58(1):184-9. PubMed ID: 22871501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C.
    Bitetto D; Fabris C; Fornasiere E; Pipan C; Fumolo E; Cussigh A; Bignulin S; Cmet S; Fontanini E; Falleti E; Martinella R; Pirisi M; Toniutto P
    Transpl Int; 2011 Jan; 24(1):43-50. PubMed ID: 20649944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review article: the extra-skeletal effects of vitamin D in chronic hepatitis C infection.
    Cholongitas E; Theocharidou E; Goulis J; Tsochatzis E; Akriviadis E; Burroughs K
    Aliment Pharmacol Ther; 2012 Mar; 35(6):634-46. PubMed ID: 22316435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of vitamin D receptor and binding protein gene polymorphisms in clinical and laboratory data of HCV patients: Cross sectional study.
    Scalioni LP; Santos BRD; Spritzer PM; Villela-Nogueira CA; Laura Lewis-Ximenez L; Pollo-Flores P; Bordalo Cathalá Esberard E; Brandão-Mello CE; Lampe E; Villar LM
    Medicine (Baltimore); 2018 Feb; 97(8):e9881. PubMed ID: 29465575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained virological response: a milestone in the treatment of chronic hepatitis C.
    Morisco F; Granata R; Stroffolini T; Guarino M; Donnarumma L; Gaeta L; Loperto I; Gentile I; Auriemma F; Caporaso N
    World J Gastroenterol; 2013 May; 19(18):2793-8. PubMed ID: 23687416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury.
    El Aggan H; Farahat N; El Deeb N; Zeid A; El-Shendidi A
    Microb Pathog; 2019 Jun; 131():65-74. PubMed ID: 30926417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.
    Mandorfer M; Reiberger T; Payer BA; Ferlitsch A; Breitenecker F; Aichelburg MC; Obermayer-Pietsch B; Rieger A; Trauner M; Peck-Radosavljevic M;
    AIDS; 2013 Jan; 27(2):227-32. PubMed ID: 23238552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C.
    Falleti E; Bitetto D; Fabris C; Fattovich G; Cussigh A; Cmet S; Ceriani E; Fornasiere E; Pasino M; Ieluzzi D; Pirisi M; Toniutto P
    Hepatology; 2012 Nov; 56(5):1641-50. PubMed ID: 22610885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients.
    Baur K; Mertens JC; Schmitt J; Iwata R; Stieger B; Frei P; Seifert B; Bischoff Ferrari HA; von Eckardstein A; Müllhaupt B; Geier A;
    Antivir Ther; 2012; 17(3):541-7. PubMed ID: 22300961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes.
    Gal-Tanamy M; Bachmetov L; Ravid A; Koren R; Erman A; Tur-Kaspa R; Zemel R
    Hepatology; 2011 Nov; 54(5):1570-9. PubMed ID: 21793032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Serum Vitamin D Levels on Cellular Immunity and Antiviral Effects in Chronic Hepatitis B Patients.
    He LJ; Zhang HP; Li HJ; Wang J; Chang DD
    Clin Lab; 2016 Oct; 62(10):1933-1939. PubMed ID: 28164523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.
    Bitetto D; Fattovich G; Fabris C; Ceriani E; Falleti E; Fornasiere E; Pasino M; Ieluzzi D; Cussigh A; Cmet S; Pirisi M; Toniutto P
    Hepatology; 2011 Apr; 53(4):1118-26. PubMed ID: 21480318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-livering the message: the importance of vitamin D status in chronic liver disease.
    Kitson MT; Roberts SK
    J Hepatol; 2012 Oct; 57(4):897-909. PubMed ID: 22634121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients.
    Guzmán-Fulgencio M; García-Álvarez M; Berenguer J; Jiménez-Sousa MÁ; Cosín J; Pineda-Tenor D; Carrero A; Aldámiz T; Alvarez E; López JC; Resino S
    J Infect; 2014 Feb; 68(2):176-84. PubMed ID: 24184809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis.
    Kitson MT; Sarrazin C; Toniutto P; Eslick GD; Roberts SK
    J Hepatol; 2014 Dec; 61(6):1247-52. PubMed ID: 25135863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?
    Ferrari SM; Fallahi P; Ruffilli I; Elia G; Ragusa F; Paparo SR; Patrizio A; Mazzi V; Colaci M; Giuggioli D; Ferri C; Antonelli A
    J Immunol Res; 2019; 2019():5878960. PubMed ID: 31485460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum vitamin D₃ does not correlate with liver fibrosis in chronic hepatitis C.
    Ren Y; Liu M; Zhao J; Ren F; Chen Y; Li JF; Zhang JY; Qu F; Zhang JL; Duan ZP; Zheng SJ
    World J Gastroenterol; 2015 Oct; 21(39):11152-9. PubMed ID: 26494969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Vitamin D Serum Levels and GC Gene Polymorphisms in Liver Fibrosis Due to Chronic Hepatitis C.
    Azevedo LA; Matte U; Silveira TR; Bonfanti JW; Bruch JP; Álvares-da-Silva MR
    Ann Hepatol; 2017; 16(5):742-748. PubMed ID: 28809744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.